Skip to main content
ATRC
NASDAQ Industrial Applications And Services

AtriCure Reports Strong Q4 & Full-Year 2025 Results, Guides for Positive 2026 Net Income

Analysis by Wiseek AI
Sentiment info
Positive
Importance info
8
Price
$32.97
Mkt Cap
$1.639B
52W Low
$28.29
52W High
$43.18
Market data snapshot near publication time

Summary

AtriCure, Inc. finalized strong Q4 and full-year 2025 financial results, reporting significant revenue growth and a return to profitability in Q4, while also issuing positive 2026 guidance including projected positive net income.


Key Events

  • Strong Q4 2025 Performance

    Reported worldwide revenue of $140.5 million, a 13.1% increase year-over-year, with net income of $1.8 million and adjusted EBITDA of $19.9 million.

  • Solid Full-Year 2025 Results

    Achieved worldwide revenue of $534.5 million, up 14.9% year-over-year, significantly reducing net loss to $11.4 million and nearly doubling adjusted EBITDA to $61.8 million.

  • Positive 2026 Financial Guidance

    Projected full-year 2026 revenue between $600 million and $610 million (12% to 14% growth), with adjusted EBITDA of $80 million to $82 million, and positive net income.

  • Operational Momentum

    Growth was driven by expanding use of new products like cryoSPHERE MAX and AtriClip FLEX-Mini, and continued adoption of the EnCompass clamp.


Analysis

AtriCure, Inc. reported robust financial results for the fourth quarter and full-year 2025, confirming the strong preliminary figures announced on January 12, 2026. The company achieved significant revenue growth and a notable improvement in profitability, moving from a net loss in 2024 to positive net income in Q4 2025. Furthermore, management provided optimistic guidance for full-year 2026, projecting continued revenue growth and, critically, positive net income, signaling a strong operational turnaround and a clear path to sustained profitability. This performance, driven by expanding product adoption, positions the company favorably for future value creation.

At the time of this filing, ATRC was trading at $32.97 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $28.29 to $43.18. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ATRC - Latest Insights

ATRC
May 19, 2026, 4:21 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $28.80
Real-time Price: $28.79 info
Change: -$0.010 (-0.03%) info
Market Cap: $1.458B info
ATRC
May 05, 2026, 9:01 PM EDT
Filing Type: 8-K/A
Importance Score:
7
Price at Filing: $30.40
Real-time Price: $28.79 info
Change: -$1.61 (-5%) info
Market Cap: $1.458B info
ATRC
May 05, 2026, 4:23 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $29.50
Real-time Price: $28.79 info
Change: -$0.710 (-2%) info
Market Cap: $1.458B info
ATRC
May 05, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $29.39
Real-time Price: $28.79 info
Change: -$0.600 (-2%) info
Market Cap: $1.458B info
ATRC
Apr 06, 2026, 11:54 AM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $29.33
Real-time Price: $28.79 info
Change: -$0.540 (-2%) info
Market Cap: $1.458B info
ATRC
Feb 19, 2026, 12:39 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $32.39
Real-time Price: $28.79 info
Change: -$3.59 (-11%) info
Market Cap: $1.458B info
ATRC
Feb 17, 2026, 4:00 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $32.97
Real-time Price: $28.79 info
Change: -$4.18 (-13%) info
Market Cap: $1.458B info
ATRC
Jan 12, 2026, 8:00 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $41.46
Real-time Price: $28.79 info
Change: -$12.67 (-31%) info
Market Cap: $1.458B info